10/14/2009 - Eli Lilly is being sued by an Illinois woman and an unknown number of plaintiffs who claim either they or their children developed a number of conditions ranging from diabetes to weight gain after taking the antipsychotic medication Zyprexa. More>>>

10/14/2009 - The Idaho attorney general's office alleged that drug manufacturer Eli Lilly marketed its top-selling drug Zyprexa deceptively and failed to warn health-care providers that patients could suffer side effects such as weight gain and diabetes More>>>

10/08/2009 - A spokeswoman for a major drug manufacturer said Wednesday that a "tentative settlement" to a lawsuit filed by the state of South Carolina has been reached. The Attorney General's office, however, said a confirmed agreement between the state and Eli Lilly & Co. does not exist. More>>>

09/22/2009 - Eli Lilly & Co. agreed to settle, on confidential terms, lawsuits filed by seven states alleging the company improperly marketed its antipsychotic drug Zyprexa, a court-appointed official said. More>>>

09/18/2009 - South Carolina government lawyers introduced damaging evidence in a court hearing in a lawsuit against the drug company, Eli Lilly. Pharmaceutical sales representatives’ notes reveal South Carolina doctors were paid for prescribing Zyprexa, a now highly debated antipsychotic, to patients. More>>>

More News ::

FDA Medication Guide ::

Zyprexa Side Effects Lawsuit:

Zyprexa ( Zyprexa Olanzapine ) is an anti-psychotic medication that was approved in 1996 by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia. It is often prescribed for other problems such as anxiety and depression. Zyprexa is a member of a class of drugs commonly referred to as "second generation anti-psychotics" ("SGA's") or "atypical anti-psychotics." When Zyprexa ( Olanzapine ) was approved in 1996, there were 2 other such SGA medications already available on the market. Consequently, Zyprexa is considered a "me-too" drug, joining a class of existing medications prescribed for the treatment of common disorders.

The SGA's were developed as an alternative to the so-called "first generation anti-psychotics" ("FGA's"). The SGA's were designed to be more effective in the treatment of anti-psychotic disorders with fewer of the side effects generally associated with the use of FGA's.

Of six SGA's currently available, Zyprexa is the most commonly prescribed. The generic name of Zyprexa is olanzapine. Zyprexa has been prescribed to more than 14 million people in 84 countries since its approval in 1996.


In September 2003, the FDA ordered Eli Lilly to revise Zyprexa's label by adding a side effects warning that "hyperglycemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients treated with atypical anti-psychotics." Among the more serious outcomes resulting from hyperglycemic abnormalities are diabetes, diabetic ketoacidosis, diabetic coma and, in some cases death. * Zyprexa weight gain is also a commonly reported side effect.

- Diabetes
- Diabetic Ketoacidosis
- Diabetic Coma
- Hyperosmolar Coma
- Hyperglycemia

If you are currently taking Zyprexa and have concerns about its safetly, you should consult with your doctor regarding your treatment options. Under no circumstances should you discontinue taking any medication, including Zyprexa, without first consulting with your doctor. For Zyprexa legal information contact the Zyprexa Attorneys of Ennis & Ennis, P.A. by filling out our free Zyrpexa case evaluation form or by calling the toll-free number listed below.